BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chu TW, Zhang R, Yang J, Chao MP, Shami PJ, Kopeček J. A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab. Theranostics 2015;5:834-46. [PMID: 26000056 DOI: 10.7150/thno.12040] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tommy Gambles M, Li J, Christopher Radford D, Sborov D, Shami P, Yang J, Kopeček J. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo. J Control Release 2022;350:584-99. [PMID: 36037975 DOI: 10.1016/j.jconrel.2022.08.045] [Reference Citation Analysis]
2 Panjideh H, Niesler N, Weng A, Fuchs H. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022;14:478. [DOI: 10.3390/toxins14070478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mahajan S, Aalhate M, Guru SK, Singh PK. Nanomedicine as a magic bullet for combating lymphoma. J Control Release 2022;347:211-36. [PMID: 35533946 DOI: 10.1016/j.jconrel.2022.05.002] [Reference Citation Analysis]
4 Kwak E, Kim T, Yang K, Kim YM, Han HS, Park KH, Choi KY, Roh YH. Surface-Functionalized Polymeric siRNA Nanoparticles for Tunable Targeting and Intracellular Delivery to Hematologic Cancer Cells. Biomacromolecules 2022. [PMID: 35362323 DOI: 10.1021/acs.biomac.1c01497] [Reference Citation Analysis]
5 Ljubimov VA, Ramesh A, Davani S, Danielpour M, Breunig JJ, Black KL. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. Adv Drug Deliv Rev 2022;181:114033. [PMID: 34808227 DOI: 10.1016/j.addr.2021.114033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang J, Yang J, Kopeček J. Nanomedicines in B cell-targeting therapies. Acta Biomater 2022;137:1-19. [PMID: 34687954 DOI: 10.1016/j.actbio.2021.10.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kalousková B, Skořepa O, Cmunt D, Abreu C, Krejčová K, Bláha J, Sieglová I, Král V, Fábry M, Pola R, Pechar M, Vaněk O. Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells. Biomedicines 2021;9:1597. [PMID: 34829829 DOI: 10.3390/biomedicines9111597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gu W, Qu R, Meng F, Cornelissen JJLM, Zhong Z. Polymeric nanomedicines targeting hematological malignancies. J Control Release 2021;337:571-88. [PMID: 34364920 DOI: 10.1016/j.jconrel.2021.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Gambles MT, Li J, Wang J, Sborov D, Yang J, Kopeček J. Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells. Molecules 2021;26:4658. [PMID: 34361811 DOI: 10.3390/molecules26154658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Tavares MR, Pechar M, Chytil P, Etrych T. Polymer-Based Drug-Free Therapeutics for Anticancer, Anti-Inflammatory, and Antibacterial Treatment. Macromol Biosci 2021;21:e2100135. [PMID: 34008348 DOI: 10.1002/mabi.202100135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Rütter M, Milošević N, David A. Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs. J Control Release 2021;330:1191-207. [PMID: 33207257 DOI: 10.1016/j.jconrel.2020.11.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bai C, Hu P, Zhang W, Song L, Liu D, Chen Y, Ma M, Gu N, Zhang Y. Modular design of Bi-specific nanoplatform engaged in malignant lymphoma immunotherapy. Nanoscale 2020;12:18418-28. [PMID: 32941572 DOI: 10.1039/d0nr04450d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Randárová E, Kudláčová J, Etrych T. HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems. Journal of Controlled Release 2020;325:304-22. [DOI: 10.1016/j.jconrel.2020.06.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Kopeček J, Yang J. Polymer nanomedicines. Adv Drug Deliv Rev 2020;156:40-64. [PMID: 32735811 DOI: 10.1016/j.addr.2020.07.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
15 Brusini R, Varna M, Couvreur P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv Drug Deliv Rev 2020;157:161-78. [PMID: 32697950 DOI: 10.1016/j.addr.2020.07.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 26.0] [Reference Citation Analysis]
16 Huang L, Huang J, Huang J, Xue H, Liang Z, Wu J, Chen C. Nanomedicine - a promising therapy for hematological malignancies. Biomater Sci 2020;8:2376-93. [PMID: 32314759 DOI: 10.1039/d0bm00129e] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
17 Wang J, Li Y, Li L, Yang J, Kopeček J. Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model. Macromol Biosci 2020;20:e1900445. [PMID: 32196951 DOI: 10.1002/mabi.201900445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Song L, Chen Y, Ding J, Wu H, Zhang W, Ma M, Zang F, Wang Z, Gu N, Zhang Y. Rituximab conjugated iron oxide nanoparticles for targeted imaging and enhanced treatment against CD20-positive lymphoma. J Mater Chem B 2020;8:895-907. [DOI: 10.1039/c9tb02521a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Verhoeven M, Seimbille Y, Dalm SU. Therapeutic Applications of Pretargeting. Pharmaceutics 2019;11:E434. [PMID: 31480515 DOI: 10.3390/pharmaceutics11090434] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
20 Zhang Y, Yong L, Luo Y, Ding X, Xu D, Gao X, Yan S, Wang Q, Luo J, Pu D, Zou J. Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model. Sci Rep 2019;9:6982. [PMID: 31061456 DOI: 10.1038/s41598-019-43416-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
21 Ma XL, Lin QY, Wang L, Xie X, Zhang YL, Li HH. Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice. Biomed Pharmacother 2019;114:108804. [PMID: 30909146 DOI: 10.1016/j.biopha.2019.108804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
22 Wang J, Li L, Yang J, Clair PM, Glenn MJ, Stephens DM, Radford DC, Kosak KM, Deininger MW, Shami PJ, Kopeček J. Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine. Nanomedicine 2019;16:217-25. [PMID: 30639670 DOI: 10.1016/j.nano.2018.12.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
23 Yang J, Li L, Kopeček J. Biorecognition: A key to drug-free macromolecular therapeutics. Biomaterials 2019;190-191:11-23. [PMID: 30391799 DOI: 10.1016/j.biomaterials.2018.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
24 Repetto-llamazares AHV, Malenge MM, O'shea A, Eiríksdóttir B, Stokke T, Larsen RH, Dahle J. Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma. Eur J Haematol 2018;101:522-31. [DOI: 10.1111/ejh.13139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
25 Chen X. Making Rituximab Directly Cytotoxic for Substantial Improvement in Therapeutic Efficacy. EMJ Hematol 2018. [DOI: 10.33590/emjhematol/10312666] [Reference Citation Analysis]
26 Li L, Yang J, Wang J, Kopeček J. Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 2018;12:3658-70. [PMID: 29595951 DOI: 10.1021/acsnano.8b00797] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
27 Luo C, Deng Z, Li L, Clayton F, Chen AL, Wei R, Miles R, Stephens DM, Glenn M, Wang X, Jensen PE, Chen X. Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells. Oncotarget 2016;7:12806-22. [PMID: 26859679 DOI: 10.18632/oncotarget.7230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
28 Pechar M, Pola R, Janoušková O, Sieglová I, Král V, Fábry M, Tomalová B, Kovář M. Polymer Cancerostatics Targeted with an Antibody Fragment Bound via a Coiled Coil Motif: In Vivo Therapeutic Efficacy against Murine BCL1 Leukemia. Macromol Biosci 2018;18:1700173. [DOI: 10.1002/mabi.201700173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
29 Li L, Yang J, Wang J, Kopeček J. Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway. Macromol Biosci 2018;18. [PMID: 28805013 DOI: 10.1002/mabi.201700196] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
30 Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen X, Cheng Z, Cui D, Du J, Dullin C, Escudero A, Feliu N, Gao M, George M, Gogotsi Y, Grünweller A, Gu Z, Halas NJ, Hampp N, Hartmann RK, Hersam MC, Hunziker P, Jian J, Jiang X, Jungebluth P, Kadhiresan P, Kataoka K, Khademhosseini A, Kopeček J, Kotov NA, Krug HF, Lee DS, Lehr CM, Leong KW, Liang XJ, Ling Lim M, Liz-Marzán LM, Ma X, Macchiarini P, Meng H, Möhwald H, Mulvaney P, Nel AE, Nie S, Nordlander P, Okano T, Oliveira J, Park TH, Penner RM, Prato M, Puntes V, Rotello VM, Samarakoon A, Schaak RE, Shen Y, Sjöqvist S, Skirtach AG, Soliman MG, Stevens MM, Sung HW, Tang BZ, Tietze R, Udugama BN, VanEpps JS, Weil T, Weiss PS, Willner I, Wu Y, Yang L, Yue Z, Zhang Q, Zhang Q, Zhang XE, Zhao Y, Zhou X, Parak WJ. Diverse Applications of Nanomedicine. ACS Nano 2017;11:2313-81. [PMID: 28290206 DOI: 10.1021/acsnano.6b06040] [Cited by in Crossref: 755] [Cited by in F6Publishing: 776] [Article Influence: 151.0] [Reference Citation Analysis]
31 Moulton JD. Using Morpholinos to Control Gene Expression. Curr Protoc Nucleic Acid Chem 2017;68:4.30.1-4.30.29. [PMID: 28252184 DOI: 10.1002/cpnc.21] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
32 Zhang L, Fang Y, Yang J, Kopeček J. Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells. J Control Release 2017;263:139-50. [PMID: 28024916 DOI: 10.1016/j.jconrel.2016.12.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
33 Chu TW, Kopeček J. Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines. Biomater Sci 2015;3:908-22. [PMID: 26191406 DOI: 10.1039/C4BM00442F] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
34 Yang J, Kopeček J. Design of smart HPMA copolymer-based nanomedicines. Journal of Controlled Release 2016;240:9-23. [DOI: 10.1016/j.jconrel.2015.10.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
35 Bortolotti M, Bolognesi A, Battelli MG, Polito L. High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin. Toxins (Basel) 2016;8:E192. [PMID: 27338475 DOI: 10.3390/toxins8060192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
36 Hartley JM, Zhang R, Gudheti M, Yang J, Kopeček J. Tracking and quantifying polymer therapeutic distribution on a cellular level using 3D dSTORM. J Control Release 2016;231:50-9. [PMID: 26855050 DOI: 10.1016/j.jconrel.2016.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
37 Yang J, Kopeček J. POLYMERIC BIOMATERIALS AND NANOMEDICINES. J Drug Deliv Sci Technol 2015;30:318-30. [PMID: 26688694 DOI: 10.1016/j.jddst.2015.05.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
38 Chu TW, Kosak KM, Shami PJ, Kopeček J. Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cells. Drug Deliv Transl Res 2014;4:389-94. [PMID: 25580376 DOI: 10.1007/s13346-014-0209-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]